{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:53:35Z","timestamp":1777560815146,"version":"3.51.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Despite the availability of new drugs on the clinics in recent years, drug-resistant epilepsy remains an unresolved challenge for healthcare, and one-third of epilepsy patients remain refractory to anti-seizure medications. Gene therapy in experimental models has emerged as effective treatment targeting specific neuronal populations in the epileptogenic focus. When combined with an external chemical activator using chemogenetics, it also becomes an \u201con-demand\u201d treatment. Here, we evaluate a targeted and specific chemogenetic therapy, the PSAM\/PSEM system, which holds promise as a potential candidate for clinical application in treating drug-resistant epilepsy. We show that the inert ligand uPSEM<jats:sup>817<\/jats:sup>, which selectively activates the chloride-permeable channel PSAM<jats:sup>4<\/jats:sup>-GlyR, effectively reduces the number of depolarization-induced action potentials in vitro. This effect is likely due to the shunting of depolarizing currents, as evidenced by decreased membrane resistance in these cells. In organotypic slices, uPSEM<jats:sup>817<\/jats:sup> decreased the number of bursts and peak amplitude of events of spontaneous epileptiform activity. Although administration of uPSEM<jats:sup>817<\/jats:sup> in vivo did not significantly alter electrographic seizures in a male mouse model of temporal lobe epilepsy, it did demonstrate a strong trend toward reducing the frequency of interictal epileptiform discharges. These findings indicate that PSAM<jats:sup>4<\/jats:sup>-GlyR-based chemogenetics holds potential as an anti-seizure strategy, although further refinement is necessary to enhance its efficacy.<\/jats:p>","DOI":"10.1038\/s41434-024-00493-7","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T16:02:03Z","timestamp":1729872123000},"page":"106-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chemogenetics with PSAM4-GlyR decreases excitability and epileptiform activity in epileptic hippocampus"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8569-5566","authenticated-orcid":false,"given":"Ana","family":"Gonzalez-Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Berglind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kudl\u00e1\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elza R.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esbj\u00f6rn","family":"Melin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Sebastia\u0303o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia A.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ledri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-138X","authenticated-orcid":false,"given":"My","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-3921","authenticated-orcid":false,"given":"Merab","family":"Kokaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"493_CR1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","volume":"18","author":"GE Collaborators","year":"2019","unstructured":"Collaborators GE. Global, regional, and national burden of epilepsy, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:357.","journal-title":"Lancet Neurol"},{"key":"493_CR2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.braindev.2012.09.002","volume":"35","author":"Y Toda","year":"2013","unstructured":"Toda Y, Kobayashi K, Hayashi Y, Inoue T, Oka M, Ohtsukaet Y. Effects of intravenous diazepam on high-frequency oscillations in EEGs with CSWS. Brain Dev. 2013;35:540\u20137.","journal-title":"Brain Dev"},{"key":"493_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2011.02.045","volume":"494","author":"B-W Peng","year":"2011","unstructured":"Peng B-W, Justice JA, Zhang K, Li J-X, He X-H, Sanchez RM. Gabapentin promotes inhibition by enhancing hyperpolarization-activated cation currents and spontaneous firing in hippocampal CA1 interneurons. Neurosci Lett. 2011;494:19\u201323.","journal-title":"Neurosci Lett"},{"key":"493_CR4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.109.153908","volume":"330","author":"MF Braga","year":"2009","unstructured":"Braga MF, Aroniadou-Anderjaska V, Li H, Rogawski MA. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J Pharmacol Exp Ther. 2009;330:558\u201366.","journal-title":"J Pharmacol Exp Ther"},{"key":"493_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0143-4179(91)90120-8","volume":"19","author":"A Ylinen","year":"1991","unstructured":"Ylinen A, Valjakka A, Lahtinen H, Miettinen R, Freund TF, Riekkinen P. Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path. Neuropeptides. 1991;19:205\u201311.","journal-title":"Neuropeptides"},{"key":"493_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/epi.12300","volume":"54","author":"TJ O\u2019Brien","year":"2013","unstructured":"O\u2019Brien TJ, Ben-Menachem E, Bertram EH 3rd, Collins SD, Kokaia M, Lerche H, et al. Proposal for a \u201cphase II\u201d multicenter trial model for preclinical new antiepilepsy therapy development. Epilepsia. 2013;54:70\u20134.","journal-title":"Epilepsia"},{"key":"493_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","volume":"75","author":"Z Chen","year":"2018","unstructured":"Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279\u201386. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3949.","journal-title":"JAMA Neurol"},{"key":"493_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1528-1157.2003.46002.x","volume":"44","author":"SD Lhatoo","year":"2003","unstructured":"Lhatoo SD, Solomon JK, McEvoy AW, Kitchen ND, Shorvon SD, Sander JW. A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom. Epilepsia. 2003;44:673\u20136.","journal-title":"Epilepsia"},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/jnnp-2014-310148","volume":"87","author":"C Fois","year":"2016","unstructured":"Fois C, Kovac S, Khalil A, Uzuner GT, Diehl B, Wehner T, et al. Predictors for being offered epilepsy surgery: 5-year experience of a tertiary referral centre. J Neurol, Neurosurg Psychiatry. 2016;87:209\u201311. https:\/\/doi.org\/10.1136\/jnnp-2014-310148.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"493_CR10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1474-4422(16)30127-2","volume":"15","author":"N Jett\u00e9","year":"2016","unstructured":"Jett\u00e9 N, Sander JW, Keezer MR. Surgical treatment for epilepsy: the potential gap between evidence and practice. Lancet Neurol. 2016;15:982\u201394.","journal-title":"Lancet Neurol"},{"key":"493_CR11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(13)70175-3","volume":"12","author":"I Blumcke","year":"2013","unstructured":"Blumcke I, Cross JH, Spreafico R. The international consensus classification for hippocampal sclerosis: an important step towards accurate prognosis. Lancet Neurol. 2013;12:844\u20136.","journal-title":"Lancet Neurol"},{"key":"493_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/107385840100700410","volume":"7","author":"J Engel Jr","year":"2001","unstructured":"Engel J Jr. Mesial temporal lobe epilepsy: what have we learned? Neuroscientist. 2001;7:340\u201352. https:\/\/doi.org\/10.1177\/107385840100700410.","journal-title":"Neuroscientist"},{"key":"493_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-014-1292-0","volume":"128","author":"F Cendes","year":"2014","unstructured":"Cendes F, Sakamoto AC, Spreafico R, Bingaman W, Becker AJ. Epilepsies associated with hippocampal sclerosis. Acta Neuropathol. 2014;128:21\u201337. https:\/\/doi.org\/10.1007\/s00401-014-1292-0.","journal-title":"Acta Neuropathol"},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/epi.12220","volume":"54","author":"I Bl\u00fcmcke","year":"2013","unstructured":"Bl\u00fcmcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE commission on diagnostic methods. Epilepsia. 2013;54:1315\u201329. https:\/\/doi.org\/10.1111\/epi.12220.","journal-title":"Epilepsia"},{"key":"493_CR15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0079-6123(07)63029-5","volume":"163","author":"TP Sutula","year":"2007","unstructured":"Sutula TP, Dudek FE. Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: an emergent property of a complex system. Prog Brain Res. 2007;163:541\u201363.","journal-title":"Prog Brain Res"},{"key":"493_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2007.07.029","volume":"149","author":"A Andrioli","year":"2007","unstructured":"Andrioli A, Alonso-Nanclares L, Arellano JI, DeFelipe J. Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus. Neuroscience. 2007;149:131\u201343.","journal-title":"Neuroscience"},{"key":"493_CR17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(89)90234-5","volume":"495","author":"N De Lanerolle","year":"1989","unstructured":"De Lanerolle N, Kim J, Robbins RJ, Spencer D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 1989;495:387\u201395.","journal-title":"Brain Res"},{"key":"493_CR18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.410290316","volume":"29","author":"RJ Robbins","year":"1991","unstructured":"Robbins RJ, Brines ML, Kim JH, Adrian T, de Lanerolle N, Welsh S, et al. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann Neurol. 1991;29:325\u201332.","journal-title":"Ann Neurol"},{"key":"493_CR19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/brain\/awh339","volume":"128","author":"L Wittner","year":"2005","unstructured":"Wittner L, Eross L, Czirj\u00e1k S, Hal\u00e1sz P, Freund TF, Magl\u00f3czky Z. Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus. Brain. 2005;128:138\u201352.","journal-title":"Brain"},{"key":"493_CR20","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/brain\/awq149","volume":"133","author":"K T\u00f3th","year":"2010","unstructured":"T\u00f3th K, Eross L, Vajda J, Hal\u00e1sz P, Freund TF, Magl\u00f3czky Z. Loss and reorganization of calretinin-containing interneurons in the epileptic human hippocampus. Brain. 2010;133:2763\u201377.","journal-title":"Brain"},{"key":"493_CR21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/1531-8249(199901)45:1<92::AID-ART15>3.0.CO;2-N","volume":"45","author":"A Williamson","year":"1999","unstructured":"Williamson A, Patrylo PR, Spencer DD. Decrease in inhibition in dentate granule cells from patients with medial temporal lobe epilepsy. Ann Neurol. 1999;45:92\u20139.","journal-title":"Ann Neurol"},{"key":"493_CR22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nn1499","volume":"8","author":"I Cobos","year":"2005","unstructured":"Cobos I, Calcagnotto ME, Vilaythong AJ, Thwin MT, Noebels JL, Baraban SC, et al. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci. 2005;8:1059\u201368.","journal-title":"Nat Neurosci"},{"key":"493_CR23","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1523\/JNEUROSCI.3456-16.2017","volume":"37","author":"M Drexel","year":"2017","unstructured":"Drexel M, Romanov RA, Wood J, Weger S, Heilbronn R, Wulff P, et al. Selective silencing of hippocampal parvalbumin interneurons induces development of recurrent spontaneous limbic seizures in mice. J Neurosci. 2017;37:8166\u201379.","journal-title":"J Neurosci"},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"15472","DOI":"10.1073\/pnas.0900141106","volume":"106","author":"SC Baraban","year":"2009","unstructured":"Baraban SC, Southwell DG, Estrada RC, Jones DL, Sebe JY, Alfaro-Cervello C, et al. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc Natl Acad Sci USA. 2009;106:15472\u20137. https:\/\/doi.org\/10.1073\/pnas.0900141106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"493_CR25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nn.3392","volume":"16","author":"RF Hunt","year":"2013","unstructured":"Hunt RF, Girskis KM, Rubenstein JL, Alvarez-Buylla A, Baraban SC. GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat Neurosci. 2013;16:692\u20137.","journal-title":"Nat Neurosci"},{"key":"493_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.stem.2014.10.006","volume":"15","author":"M Cunningham","year":"2014","unstructured":"Cunningham M, Cho J-H, Leung A, Savvidis G, Ahn S, Moon M, et al. hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell. 2014;15:559\u201373. https:\/\/doi.org\/10.1016\/j.stem.2014.10.006.","journal-title":"Cell Stem Cell"},{"key":"493_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1073\/pnas.1814185115","volume":"116","author":"D Upadhya","year":"2019","unstructured":"Upadhya D, Hattiangady B, Castro OW, Shuai B, Kodali M, Attaluri S, et al. Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration. Proc Natl Acad Sci USA. 2019;116:287\u201396. https:\/\/doi.org\/10.1073\/pnas.1814185115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"493_CR28","doi-asserted-by":"crossref","first-page":"13243","DOI":"10.3390\/ijms222413243","volume":"22","author":"E Waloschkov\u00e1","year":"2021","unstructured":"Waloschkov\u00e1 E, Gonzalez-Ramos A, Mikroulis A, Kudl\u00e1\u010dek J, Andersson M, Ledri M, et al. Human stem sell-derived GABAergic interneurons establish efferent synapses onto host neurons in rat epileptic hippocampus and inhibit spontaneous recurrent seizures. Int J Mol Sci. 2021;22:13243.","journal-title":"Int J Mol Sci"},{"key":"493_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fncel.2018.00293","volume":"12","author":"A C\u01celin","year":"2018","unstructured":"C\u01celin A, Stancu M, Zagrean A-M, Jefferys JGR, Ilie AS, Akerman C. Chemogenetic recruitment of specific interneurons suppresses seizure activity. Front Cell Neurosci. 2018;12:293 https:\/\/doi.org\/10.3389\/fncel.2018.00293.","journal-title":"Front Cell Neurosci"},{"key":"493_CR30","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/brain\/awq219","volume":"133","author":"DPD Woldbye","year":"2010","unstructured":"Woldbye DPD, Angehagen M, G\u00f8tzsche CR, Elbr\u00f8nd-Bek H, S\u00f8rensen AT, Christiansen SH, et al. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures. Brain. 2010;133:2778\u201388. https:\/\/doi.org\/10.1093\/brain\/awq219.","journal-title":"Brain"},{"key":"493_CR31","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nm901","volume":"9","author":"RP Haberman","year":"2003","unstructured":"Haberman RP, Samulski RJ, McCown TJ. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med. 2003;9:1076\u201380. https:\/\/doi.org\/10.1038\/nm901.","journal-title":"Nat Med"},{"key":"493_CR32","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/brain\/awn079","volume":"131","author":"F No\u00e8","year":"2008","unstructured":"No\u00e8 F, Pool A-H, Nissinen J, Gobbi M, Bland R, Rizzi M, et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain. 2008;131:1506\u201315. https:\/\/doi.org\/10.1093\/brain\/awn079.","journal-title":"Brain"},{"key":"493_CR33","doi-asserted-by":"crossref","first-page":"161ra152","DOI":"10.1126\/scitranslmed.3004190","volume":"4","author":"RC Wykes","year":"2012","unstructured":"Wykes RC, Heeroma J-H, Mantoan L, Zheng K, MacDonald DC, Deisseroth K, et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci Transl Med. 2012;4:161ra152\u2013161ra152.","journal-title":"Sci Transl Med"},{"key":"493_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4939-3271-9_10","volume":"1382","author":"MJ Castle","year":"2016","unstructured":"Castle MJ, Turunen HT, Vandenberghe LH, Wolfe JH. Controlling AAV tropism in the nervous system with natural and engineered capsids. Methods Mol Biol. 2016;1382:133\u201349. https:\/\/doi.org\/10.1007\/978-1-4939-3271-9_10.","journal-title":"Methods Mol Biol"},{"key":"493_CR35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nbd.2018.06.006","volume":"117","author":"Y Wang","year":"2018","unstructured":"Wang Y, Liang J, Chen L, Shen Y, Zhao J, Xu C, et al. Pharmaco-genetic therapeutics targeting parvalbumin neurons attenuate temporal lobe epilepsy. Neurobiol Dis. 2018;117:149\u201360.","journal-title":"Neurobiol Dis"},{"key":"493_CR36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fncel.2018.00293","volume":"12","author":"A C\u01celin","year":"2018","unstructured":"C\u01celin A, Stancu M, Zagrean A-M, Jefferys JGR, Ilie AS1, Akerman CJ. Chemogenetic recruitment of specific interneurons suppresses seizure activity. Front Cell Neurosci. 2018;12:293.","journal-title":"Front Cell Neurosci"},{"key":"493_CR37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/gt.2016.56","volume":"23","author":"N Avaliani","year":"2016","unstructured":"Avaliani N, Andersson M, Runegaard A, Woldbye D, Kokaia M. DREADDs suppress seizure-like activity in a mouse model of pharmacoresistant epileptic brain tissue. Gene Ther. 2016;23:760\u20136.","journal-title":"Gene Ther"},{"key":"493_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4847","volume":"5","author":"D K\u00e4tzel","year":"2014","unstructured":"K\u00e4tzel D, Nicholson E, Schorge S, Walker MC, Kullmann DM. Chemical\u2013genetic attenuation of focal neocortical seizures. Nat Commun. 2014;5:1\u20139.","journal-title":"Nat Commun"},{"key":"493_CR39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI95731","volume":"129","author":"Q-G Zhou","year":"2019","unstructured":"Zhou Q-G, et al. Chemogenetic silencing of hippocampal neurons suppresses epileptic neural circuits. J Clin Investig. 2019;129:310\u201323.","journal-title":"J Clin Investig"},{"key":"493_CR40","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/epi.16368","volume":"60","author":"J Desloovere","year":"2019","unstructured":"Desloovere J, Boon P, Larsen LE, Merckx C, Goossens M-G, Van den Haute C, et al. Long\u2010term chemogenetic suppression of spontaneous seizures in a mouse model for temporal lobe epilepsy. Epilepsia. 2019;60:2314\u201324.","journal-title":"Epilepsia"},{"key":"493_CR41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aan2475","volume":"357","author":"JL Gomez","year":"2017","unstructured":"Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, et al. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science. 2017;357:503\u20137.","journal-title":"Science"},{"key":"493_CR42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","volume":"62","author":"K Alper","year":"2007","unstructured":"Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345\u201354.","journal-title":"Biol Psychiatry"},{"key":"493_CR43","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1206606","volume":"333","author":"CJ Magnus","year":"2011","unstructured":"Magnus CJ, Lee PH, Atasoy D, Su HH, Looger LL, Sternson SM. Chemical and genetic engineering of selective ion channel-ligand interactions. Science. 2011;333:1292\u20136. https:\/\/doi.org\/10.1126\/science.1206606.","journal-title":"Science"},{"key":"493_CR44","doi-asserted-by":"publisher","unstructured":"Magnus CJ, Lee PH, Bonaventura J, Zemla R, Gomez JL Ramirez MH, et al. Ultrapotent chemogenetics for research and potential clinical applications. Science. 2019;364. https:\/\/doi.org\/10.1126\/science.aav5282.","DOI":"10.1126\/science.aav5282"},{"key":"493_CR45","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1523\/jneurosci.23-06-02440.2003","volume":"23","author":"M Kobayashi","year":"2003","unstructured":"Kobayashi M, Buckmaster PS. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci. 2003;23:2440\u201352. https:\/\/doi.org\/10.1523\/jneurosci.23-06-02440.2003.","journal-title":"J Neurosci"},{"key":"493_CR46","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1523\/jneurosci.5342-11.2012","volume":"32","author":"W Zhang","year":"2012","unstructured":"Zhang W, Huguenard JR, Buckmaster PS. Increased excitatory synaptic input to granule cells from hilar and CA3 regions in a rat model of temporal lobe epilepsy. J Neurosci. 2012;32:1183\u201396. https:\/\/doi.org\/10.1523\/jneurosci.5342-11.2012.","journal-title":"J Neurosci"},{"key":"493_CR47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/s0079-6123(07)63032-5","volume":"163","author":"D Hsu","year":"2007","unstructured":"Hsu D. The dentate gyrus as a filter or gate: a look back and a look ahead. Prog Brain Res. 2007;163:601\u201313. https:\/\/doi.org\/10.1016\/s0079-6123(07)63032-5.","journal-title":"Prog Brain Res"},{"key":"493_CR48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2012.00065","volume":"3","author":"P Bregestovski","year":"2012","unstructured":"Bregestovski P, Bernard C. Excitatory GABA: how a correct observation may turn out to be an experimental artifact. Front Pharmacol. 2012;3:65.","journal-title":"Front Pharmacol"},{"key":"493_CR49","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.1076510","volume":"298","author":"I Cohen","year":"2002","unstructured":"Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science. 2002;298:1418\u201321.","journal-title":"Science"},{"key":"493_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2376","volume":"4","author":"E Krook-Magnuson","year":"2013","unstructured":"Krook-Magnuson E, Armstrong C, Oijala M, Soltesz I. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat Commun. 2013;4:1\u20138.","journal-title":"Nat Commun"},{"key":"493_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/cns.12523","volume":"22","author":"V Duveau","year":"2016","unstructured":"Duveau V, Pouyatos B, Bressand K, Bouyssi\u00e8res C, Chabrol T, Roche Y, et al. Differential effects of antiepileptic drugs on focal seizures in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. CNS Neurosci Ther. 2016;22:497\u2013506. https:\/\/doi.org\/10.1111\/cns.12523.","journal-title":"CNS Neurosci Ther"},{"key":"493_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuron.2012.01.007","volume":"73","author":"MH Kole","year":"2012","unstructured":"Kole MH, Stuart GJ. Signal processing in the axon initial segment. Neuron. 2012;73:235\u201347. https:\/\/doi.org\/10.1016\/j.neuron.2012.01.007.","journal-title":"Neuron"},{"key":"493_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12974-018-1225-2","volume":"15","author":"DM Magalh\u00e3es","year":"2018","unstructured":"Magalh\u00e3es DM, Pereira N, Rombo DM, Beltr\u00e3o-Cavacas C, Sebasti\u00e3o AM, Valente CA. Ex vivo model of epilepsy in organotypic slices - a new tool for drug screening. J Neuroinflamm 2018;15:203 https:\/\/doi.org\/10.1186\/s12974-018-1225-2.","journal-title":"J Neuroinflamm"},{"key":"493_CR54","doi-asserted-by":"publisher","first-page":"e61330","DOI":"10.3791\/61330","volume":"169","author":"CA Valente","year":"2021","unstructured":"Valente CA, Meda FJ, Carvalho M, Sebasti\u00e3o AM. A model of epileptogenesis in rhinal cortex-hippocampus organotypic slice cultures. J Vis Exp 2021;169:e61330 https:\/\/doi.org\/10.3791\/61330.","journal-title":"J Vis Exp"},{"key":"493_CR55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther. 2000;1:4.","journal-title":"Mol Ther"},{"key":"493_CR56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0301-0082(00)00026-5","volume":"63","author":"M de Curtis","year":"2001","unstructured":"de Curtis M, Avanzini G. Interictal spikes in focal epileptogenesis. Progr Neurobiol. 2001;63:541\u201367.","journal-title":"Progr Neurobiol"},{"key":"493_CR57","doi-asserted-by":"publisher","first-page":"e73541","DOI":"10.7554\/eLife.73541","volume":"11","author":"EH Smith","year":"2022","unstructured":"Smith EH, Liou J-Y, Merricks EM, Davis T, Thomson K, Greger B, et al. Human interictal epileptiform discharges are bidirectional traveling waves echoing ictal discharges. Elife. 2022;11:e73541. https:\/\/doi.org\/10.7554\/eLife.73541.","journal-title":"Elife"},{"key":"493_CR58","unstructured":"Miles R, Blaesse P, Huberfeld G, Wittner L, Kaila K. In: Jasper\u2019s Basic Mechanisms of the Epilepsies. Noebels JL, Michael AR, Antonio VD-E, Jeffrey LN, Massimo Avol, and Richard WO, editors. National Center for Biotechnology Information: US; 2012."},{"key":"493_CR59","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41591-018-0103-x","volume":"24","author":"A Lieb","year":"2018","unstructured":"Lieb A, Qiu Y, Dixon CL, Heller JP, Walker MC, Schorge S, et al. Biochemical autoregulatory gene therapy for focal epilepsy. Nat Med. 2018;24:1324\u20139. https:\/\/doi.org\/10.1038\/s41591-018-0103-x.","journal-title":"Nat Med"},{"key":"493_CR60","doi-asserted-by":"publisher","unstructured":"Desloovere J, Boon P, Larsen LE, Goossens M-G, Delbeke J, Carrette E, et al. Chemogenetic seizure control with clozapine and the novel ligand JHU37160 outperforms the effects of levetiracetam in the intrahippocampal Kainic Acid Mouse Model. Neurotherapeutics. 2021. https:\/\/doi.org\/10.1007\/s13311-021-01160-0.","DOI":"10.1007\/s13311-021-01160-0"},{"key":"493_CR61","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1073\/pnas.1821227116","volume":"116","author":"WD Hendricks","year":"2019","unstructured":"Hendricks WD, Westbrook GL, Schnell E. Early detonation by sprouted mossy fibers enables aberrant dentate network activity. Proc Natl Acad Sci. 2019;116:10994\u20139. https:\/\/doi.org\/10.1073\/pnas.1821227116.","journal-title":"Proc Natl Acad Sci"},{"key":"493_CR62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1152\/jn.1989.62.1.126","volume":"62","author":"JL Stringer","year":"1989","unstructured":"Stringer JL, Williamson JM, Lothman EW. Induction of paroxysmal discharges in the dentate gyrus: frequency dependence and relationship to afterdischarge production. J Neurophysiol. 1989;62:126\u201335.","journal-title":"J Neurophysiol"},{"key":"493_CR63","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.celrep.2019.10.100","volume":"29","author":"JJ Botterill","year":"2019","unstructured":"Botterill JJ, Lu Y-L, LaFrancois JJ, Bernstein HL, Alcantara-Gonzalez D, Jain S, et al. An excitatory and epileptogenic effect of dentate gyrus mossy cells in a mouse model of epilepsy. Cell Rep. 2019;29:2875\u201389.e2876. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.100.","journal-title":"Cell Rep"},{"key":"493_CR64","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1021\/acschemneuro.2c00525","volume":"13","author":"J Raper","year":"2022","unstructured":"Raper J, Eldridge MAG, Sternson SM, Shim JY, Fomani GP, Richmond BJ, et al. Characterization of ultrapotent chemogenetic ligands for research applications in nonhuman primates. ACS Chem Neurosci. 2022;13:3118\u201325. https:\/\/doi.org\/10.1021\/acschemneuro.2c00525.","journal-title":"ACS Chem Neurosci"},{"key":"493_CR65","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2017.07.009","volume":"170","author":"D Wacker","year":"2017","unstructured":"Wacker D, Stevens RC, Roth BL. How ligands illuminate GPCR molecular pharmacology. Cell. 2017;170:414\u201327. https:\/\/doi.org\/10.1016\/j.cell.2017.07.009.","journal-title":"Cell"},{"key":"493_CR66","doi-asserted-by":"publisher","first-page":"19197","DOI":"10.1073\/pnas.0906593106","volume":"106","author":"JM Guettier","year":"2009","unstructured":"Guettier JM, Gautam D, Scarselli M, Ruiz de Azua I, Li JH, et al. A chemical-genetic approach to study G protein regulation of beta cell function in vivo. Proc Natl Acad Sci. 2009;106:19197\u2013202. https:\/\/doi.org\/10.1073\/pnas.0906593106.","journal-title":"Proc Natl Acad Sci"},{"key":"493_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/026988110001400403","volume":"14","author":"KJ Aitchison","year":"2000","unstructured":"Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, et al. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice. J Psychopharmacol. 2000;14:353\u20139. https:\/\/doi.org\/10.1177\/026988110001400403.","journal-title":"J Psychopharmacol"},{"key":"493_CR68","doi-asserted-by":"publisher","first-page":"e95392","DOI":"10.1371\/journal.pone.0095392","volume":"9","author":"AJ Boender","year":"2014","unstructured":"Boender AJ, de Jong JW, Boekhoudt L, Luijendijk MCM, van der Plasse G, Adan RAH. Combined use of the canine adenovirus-2 and DREADD-technology to activate specific neural pathways in vivo. PLoS One. 2014;9:e95392 https:\/\/doi.org\/10.1371\/journal.pone.0095392.","journal-title":"PLoS One"},{"key":"493_CR69","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.neuron.2016.01.040","volume":"89","author":"BL Roth","year":"2016","unstructured":"Roth BL. DREADDs for neuroscientists. Neuron. 2016;89:683\u201394. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.040.","journal-title":"Neuron"},{"key":"493_CR70","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1073\/pnas.0700293104","volume":"104","author":"BN Armbruster","year":"2007","unstructured":"Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci. 2007;104:5163\u20138. https:\/\/doi.org\/10.1073\/pnas.0700293104.","journal-title":"Proc Natl Acad Sci"},{"key":"493_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22116-z","volume":"8","author":"DF Manvich","year":"2018","unstructured":"Manvich DF, Webster KA, Foster SL, Farrell MS, Ritchie JC, Porter JH, et al. The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. Sci Rep. 2018;8:1\u201310.","journal-title":"Sci Rep"},{"key":"493_CR72","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.tips.2019.04.010","volume":"40","author":"O Yizhar","year":"2019","unstructured":"Yizhar O, Wiegert JS. Designer drugs for designer receptors: unlocking the translational potential of chemogenetics. Trends Pharmacol Sci. 2019;40:362\u20134. https:\/\/doi.org\/10.1016\/j.tips.2019.04.010.","journal-title":"Trends Pharmacol Sci"},{"key":"493_CR73","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ebiom.2019.04.059","volume":"43","author":"A Lieb","year":"2019","unstructured":"Lieb A, Weston M, Kullmann DM. Designer receptor technology for the treatment of epilepsy. EBioMedicine. 2019;43:641\u20139. https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.059.","journal-title":"EBioMedicine"},{"key":"493_CR74","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1002\/cpns.103","volume":"93","author":"M Negrini","year":"2020","unstructured":"Negrini M, Wang G, Heuer A, Bj\u00f6rklund T, Davidsson M. AAV production everywhere: a simple, fast, and reliable protocol for in-house AAV vector production based on chloroform extraction. Curr Protoc Neurosci. 2020;93:e103 https:\/\/doi.org\/10.1002\/cpns.103.","journal-title":"Curr Protoc Neurosci"},{"key":"493_CR75","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A. Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev. 2020;72:606\u201338. https:\/\/doi.org\/10.1124\/pr.120.019539.","journal-title":"Pharmacol Rev"},{"key":"493_CR76","doi-asserted-by":"crossref","unstructured":"Lentini C, d\u2019Orange M, Marichal N, Trottmann M-M, Vignoles R, Foucault, L, et al. Reprogramming reactive glia into interneurons reduces chronic seizure activity in a mouse model of mesial temporal lobe epilepsy. Cell Stem Cell. 2021;28:2104\u201321.e10.","DOI":"10.1016\/j.stem.2021.09.002"},{"key":"493_CR77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.expneurol.2005.01.029","volume":"194","author":"D Arabadzisz","year":"2005","unstructured":"Arabadzisz D, Antal K, Parpan F, Emri Z, Fritschy J-M. Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus. Exp Neurol. 2005;194:76\u201390.","journal-title":"Exp Neurol"},{"key":"493_CR78","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","volume":"112","author":"V Riban","year":"2002","unstructured":"Riban V, Bouilleret V, Pham-L\u00ea BT, Fritschy J-M, Marescaux C, Depaulis A. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience. 2002;112:101\u201311. https:\/\/doi.org\/10.1016\/S0306-4522(02)00064-7.","journal-title":"Neuroscience"},{"key":"493_CR79","doi-asserted-by":"publisher","unstructured":"Zeidler, Z, Brandt-Fontaine M, Leintz C, Krook-Magnuson C, Netoff T, Krook-Magnuson E. Targeting the mouse ventral hippocampus in the intrahippocampal Kainic Acid Model of temporal lobe epilepsy. eNeuro. 2018;5. https:\/\/doi.org\/10.1523\/eneuro.0158-18.2018.","DOI":"10.1523\/eneuro.0158-18.2018"},{"key":"493_CR80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32:281\u201394. https:\/\/doi.org\/10.1016\/0013-4694(72)90177-0.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"493_CR81","unstructured":"Hokanson J (2021). AD Instruments (LabChart) SDK. GitHub. 2021. https:\/\/github.com\/JimHokanson\/adinstruments_sdk_matlab."},{"key":"493_CR82","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/nprot.2006.312","volume":"1","author":"J Bischofberger","year":"2006","unstructured":"Bischofberger J, Engel D, Li L, Geiger JRP, Jonas P. Patch-clamp recording from mossy fiber terminals in hippocampal slices. Nat Protoc. 2006;1:2075\u201381. https:\/\/doi.org\/10.1038\/nprot.2006.312.","journal-title":"Nat Protoc"},{"key":"493_CR83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","volume":"108","author":"WW Anderson","year":"2001","unstructured":"Anderson WW, Collingridge GL. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J Neurosci Methods. 2001;108:71\u201383.","journal-title":"J Neurosci Methods"},{"key":"493_CR84","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.nbd.2011.11.001","volume":"45","author":"Y Berdichevsky","year":"2012","unstructured":"Berdichevsky Y, Dzhala V, Mail M, Staley KJ. Interictal spikes, seizures and ictal cell death are not necessary for post-traumatic epileptogenesis in vitro. Neurobiol Dis 2012;45:774\u201385.","journal-title":"Neurobiol Dis"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00493-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T13:18:55Z","timestamp":1742995135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-024-00493-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1038\/s41434-024-00493-7","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As described in the material and methods section, the experimental procedures performed were approved by the Malm\u00f6\/Lund Animal Research Ethics Board, ethical permit number 2998\/2020-m, and conducted in agreement with the Swedish Animal Welfare Agency regulations and the EU Directive 2010\/63\/EU for animal experiments. Organotypic slices experiments were conducted according to European Union Guidelines (2012\/707\/EU) and to the Portuguese legislative action (DL 113\/2013) for the protection of animals used for scientific purposes. The methods described were approved by \u201ciMM\u2019s Institutional Animal Welfare Body (ORBEA-iMM, Lisboa, Portugal) and authorized by the Portuguese authority for Animal Welfare (Dire\u00e7\u00e3o Geral de Alimenta\u00e7\u00e3o e Veterin\u00e1ria - DGAV).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}